ArticleBMC genomics2025
Maternal lineage diversity and health-related haplogroups in the Gilgiti and Kohistani populations of northern Pakistan.
Article in BMC genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Mitochondrial DNA (mtDNA) is a crucial genetic marker for tracing maternal ancestry, understanding population history, and identifying disease-associated variants. Northern Pakistan, particularly the Kohistani and Gilgiti populations, lies at a historically significant crossroads of human migration, yet remains genetically understudied. Previous studies on these populations have primarily focused on the mtDNA control region, limiting insights into their genetic diversity, demographic history, and health-related mutations. A comprehensive whole mitogenome analysis is essential to bridge this gap and provide a more complete understanding of their genetic landscape. This study presents the first whole mitogenome analysis of the Kohistani and Gilgiti populations, leveraging next-generation sequencing to examine 120 complete mitochondrial genomes. This approach allows for a more detailed exploration of genetic diversity, population structure, and disease-associated mutations. Our primary focus is to investigate population history, genetic affinities, and clinically relevant mtDNA variations in these groups, contributing to both evolutionary genetics and precision medicine. We observed high genetic diversity, with balancing selection evident in the Gilgiti population and signals of recent expansion in the Kohistani group. Additionally, we identified mtDNA mutations associated with Leber's Hereditary Optic Neuropathy (m.11778G > A, m.14484T > C), which are well established pathogenic variants known to exhibit incomplete penetrance in other populations, as well as MIDD and MELAS (m.3243 A > G) and metabolic syndrome (m.10398 A > G), revealing population-specific health risks that warrant cautious interpretation. These findings highlight the importance of population-specific genetic studies for disease risk assessment and healthcare planning. By characterizing the mitogenomic landscape of these populations, our study provides critical insights into the genetic history in Kohistani and Gilgiti population and biomedical significance. Overall, this work not only enriches our understanding of human migration dynamics in Northern Pakistan but also establishes a valuable reference for future anthropological and biomedical research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.